Search

Start typing to see results...

  • Home
  • >
  • Stock Market
  • >
  • Ind Swift Laboratories Ltd

Ind Swift Laboratories Ltd share price and stock overview

Ind Swift Laboratories Ltd (NSE: INDSWFTLAB, BSE: 532305) operates in the Pharmaceuticals - Indian - Bulk Drugs & Formln sector. The stock has an ISIN of INE915B01019 and a face value of Rs 10. As of 02 October 2026, it trades at Rs (395.15) with a market capitalisation of Rs 3361.06 crore. Figures are live and subject to change.

Ind Swift Laboratories Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln
NSE BSE
395.15 6.40 (1.65%) upARrowC
As on: 02-Oct-2026 , 04:28 AM
Market Cap(₹Cr) 3361.06
Book Value(₹Cr) 157.5290726
BSE Code : 532305 NSE Symbol : INDSWFTLAB EPS(TTM) : 7.68 ISIN Demat : INE915B01019 P/E(TTM) : 50.33 Face Value(₹) : 10 Div & Yield % : 0

Today Market

Stock Performance

Today Market

Today's High

72,572.90

Todday's Low

71,292.88

Open at

72,192.89

Previous Close

72,480.29

Volumes

Avg Price

-570.59

Historical Performance

News

28 Sep 26
Ind-Swift Laboratories restricts trading for insiders ahead of September 2026 results
Ind-Swift Laboratories Ltd. will close its trading window for promoters, members of the promoter group, directors, key managerial personnel, designated persons, connected persons/insiders and their immediate relatives from October 1, 2026, until 48 hours after the declaration of unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, in compliance with securities regulations and the company’s code of fair disclosure.
17 Sep 26
Ind-Swift Laboratories allotted warrants valued at Rs 34.3 crore to Essix Biosciences
Ind-Swift Laboratories Limited announced that its Preferential Issue Committee approved the allotment of 70,00,000 fully convertible warrants at a price of Rs 196 per warrant, including a premium of Rs 186, to Essix Biosciences Limited, an entity belonging to the ‘Promoter & Promoter Group,’ for a total subscription price of Rs 34,30,00,000.
02 Sep 26
IND-SWIFT Laboratories appoints Amit Mathur as Additional Director for five years
IND-SWIFT LABORATORIES LTD. announced the appointment of Mr. Amit Mathur as an Additional Director, in the category of Non-Executive Independent Director, effective September 3, 2026, for a period of five years subject to member approval at the company’s 31st Annual General Meeting, scheduled for September 30, 2026.
11 Aug 26
Ind-Swift Laboratories Ltd leads gainers in 'B' group
Shekhawati Industries Ltd, Kolte Patil Developers Ltd, Bhartiya International Ltd and Godavari Biorefineries Ltd are among the other gainers in the BSE's 'B' group today, 11 August 2026.

Historical Prices

Share Price Chart

Historical Share Price

From Date:
To Date:     
Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
01-10-26 388.60 409.90 379.50 395.15 749983 19499 296571563.10 22421.95
30-09-26 417.25 424.75 382.00 388.75 805121 14719 323060185.00 22620.45
29-09-26 409.10 417.25 403.15 413.10 445415 10189 182757238.65 22716.20
28-09-26 399.75 419.40 399.60 408.10 598696 13255 244788232.05 22780.25
25-09-26 398.00 410.00 395.00 404.35 441614 10179 178851915.65 23140.50
24-09-26 403.00 419.80 393.60 401.25 641089 15307 261028519.40 23063.10
23-09-26 409.00 412.00 391.95 405.05 807681 18802 325308719.05 23446.80
22-09-26 388.00 417.00 386.20 405.55 2018474 42027 816351332.75 23329.00
21-09-26 372.90 386.00 371.00 379.40 762788 15107 288190457.80 23414.30
18-09-26 377.55 385.15 368.00 373.25 399757 9177 150057370.05 23346.40
123...

Fundamentals

Company Valuation

Market Cap (₹cr)

3361.06

PE Ratio

50.33

PB Ratio

2.45

Dividend Yield

0

ROE

3.66

ROCE

4.39

Book Value (₹)

157.5290726

Face Value (₹)

10

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 32882521 37.81 32882521 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 4451757 5.12 4451757 19
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 37334278 42.93 37334278 20
Total ShareHolding for Promoter & Group 37334278 42.93 37334278 20
plus   Publice Share Holding
plus  Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 76 0.00 76 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 9479170 10.90 9479170 14
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 300 0.00 300 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 134000 0.15 134000 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 9613546 11.05 9613546 19
plus  Non Institution
Bodies Corporate 5465186 6.28 5455386 254
Clearing Members 93225 0.11 93225 27
Directors & their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2015605 2.32 2015605 570
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 943157 1.08 943157 949
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 18965301 21.81 18965301 140
Individuals holding nominal share capital up to Rs. 1 lakh 11648055 13.39 11527707 40101
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 712770 0.82 712770 4
Sub Total 40013734 46.01 39883586 42073
Total Public Shareholding 49627280 57.07 49497132 42092
Total of Promoter & Public ShareHolding 86961558 100.00 86831410 42112
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total 86961558 100.00 86831410 42112

Financials (₹ in cr)

Consolidated Standalone
Year EndMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Net Sales649.14574.241,280.901,207.311,038.73
OPM (%)9.516.0215.249.371.21
OP61.7634.59195.17113.1712.53
Other Income46.9768.8645.3733.5043.50
PBIDT82.77285.20686.16236.05239.12
INTEREST1.402.9251.1092.1795.55
PBDT81.36282.28635.06143.88143.57
PBT39.75481.00968.3559.8712.53
EO-11.01223.20386.59-26.650.00
PBT after EO50.76257.80581.7686.5212.53
TAXES7.737.27160.3138.6914.68
PAT43.12250.48420.9647.60-2.15
EPS5.0335.2171.248.10-0.36
Raw Material42.6439.0446.7754.4655.44
Power and Fuel2.532.394.806.305.63
Employee Cost21.3420.4711.9311.2512.24
Other Manufacturing Expenses2.541.830.250.140.14
Selling and Administration Expenses16.7719.396.575.596.39
Miscellaneous Expenses1.292.431.830.181.50
Revenue (Growth %) 13.04-55.176.1016.2316.54
PBIDT (Growth %)-70.98-58.44190.69-1.2816.35
PAT (Growth %) -82.78-40.50784.44-2,314.72-31.71
PBIDT (Margin %)12.7549.6753.5719.5523.02
PAT (Margin %) 6.6443.6232.863.94-0.21

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Share Capital 86.8482.9481.4159.8159.8159.81
Reserves Total 1283.861021.24730.94615.54572.75578.89
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.0074.100.000.000.000.00
Total Shareholders Funds1370.701178.28812.35675.35632.56638.70
Secured Loans 9.314.694.87839.41929.23963.53
Unsecured Loans 8.6010.64194.7314.3414.8832.94
Total Debt17.9115.33199.60853.75944.11996.47
Other Liabilities19.8018.8616.4317.9117.1815.90
Total Liabilities1408.411212.471028.381547.011593.851651.07
APPLICATION OF FUNDS :
Gross Block 699.01654.54562.881333.471318.521316.03
Less : Accumulated Depreciation 395.24381.57371.21746.04689.03563.62
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 303.77272.97191.67587.43629.49752.41
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress12.410.0051.247.7110.3118.84
Producing Properties0.000.000.000.000.000.00
Investments 330.45268.91167.2185.12110.6855.33
Current Assets, Loans & Advances
Inventories 142.98107.2564.09427.54414.00354.41
Sundry Debtors 188.77160.23258.74469.49428.35400.15
Cash and Bank Balance414.99410.09487.629.969.389.95
Loans and Advances 116.2776.8041.71167.08146.44101.29
Total Current Assets863.01754.37852.161074.07998.16865.80
Less : Current Liabilities and Provisions
Current Liabilities 243.15203.68377.76229.39204.12165.44
Provisions 2.785.912.2511.874.960.69
Total Current Liabilities & Provisions245.93209.59380.02241.26209.08166.14
Net Current Assets617.08544.78472.14832.81789.08699.67
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets70.8968.8651.6629.8550.38132.27
Deferred Tax Liability20.5624.220.460.000.0073.42
Net Deferred Tax50.3344.6451.2029.8550.3858.85
Other Assets94.3781.1794.924.103.8965.97
Total Assets1408.421212.471028.391547.011593.841651.07
Contingent Liabilities66.3866.451.707.9735.6840.09

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Financing Activities -139.59-168.41657.7877.44145.26
Investing Activities 2.76-13.69-27.71-109.67-100.16
Net Cash Flow -0.570.58464.33-77.534.90
Operating Activities 136.26182.67-165.74-45.30-40.19

Peers

Balance Sheet Financial Ratios Profit & Loss
Aarti Pharmalabs...

968.50

(+1.55%)
Accent Microcell...

669.90

(-0.70%)
Accretion Pharma...

203.30

(-5.00%)
Achyut Healthcar...

Advanced Enzyme ...

274.25

(-2.61%)
Akums Drugs & Ph...

813.10

(-0.66%)
Albert David Ltd

856.70

(-1.78%)
Alembic Pharmace...

815.25

(-1.24%)

Corporate Actions

Bonus Dividends Splits
DateCorporate ActionInformation
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer
NRM
N R Munjal
Chairman / Executive Director / M D / Promoter
Executive
Functional Directors
RM
Rishav Mehta
Executive Director
Exec.
SM
Sahil Munjal
Executive Director
Exec.
Independent Directors
NC
Neerja Chathley
Independent Non Executive Women Director
Ind.
RKG
Rajinder Kumar Gupta
Independent Non Exe. Director
Ind.
SG
SUBODH GUPTA
Independent Non Exe. Director
Ind.
PK
Prabhat Khurana
Independent Non Exe. Director
Ind.
Company Secretary & Compliance
PV
Pradeep Verma
VP / Company Secretary / Compliance Officer
Sec.
Other Officials
HJ
Himanshu Jain
ED / Joint MD / Promoter
Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Ind Swift Laboratories Ltd? −

Ind Swift Laboratories Ltd trades on NSE under INDSWFTLAB and on BSE under code 532305. The ISIN is INE915B01019 and the face value is Rs 10.

What is the share price of Ind Swift Laboratories Ltd today? +

As of 02 October 2026, Ind Swift Laboratories Ltd trades at Rs 395.15, a change of 6.40 (1.65%) on the day. Prices are live and subject to change.

What is the market capitalisation of Ind Swift Laboratories Ltd? +

As of 02 October 2026, Ind Swift Laboratories Ltd has a market cap of about Rs 3361.06 crore. This figure is live and moves with the share price.

Is Ind Swift Laboratories Ltd profitable? +

In March 2026, Ind Swift Laboratories Ltd reported a profit after tax of Rs 43.12 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Ind Swift Laboratories Ltd? +

: As of 02 October 2026, the PE (TTM) for Ind Swift Laboratories Ltd is 50.33 and the price-to-book ratio is 2.45. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Ind Swift Laboratories Ltd pay a dividend? +

As of 02 October 2026, the dividend yield for Ind Swift Laboratories Ltd is 0%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Ind Swift Laboratories Ltd? +

As of the latest disclosed pattern, promoters hold 42.93% of Ind Swift Laboratories Ltd. Public shareholding is 57.07%, including mutual funds at 0.00% and foreign institutional investors at 10.90%.

What were the latest annual financials of Ind Swift Laboratories Ltd? +

In March 2026, Ind Swift Laboratories Ltd reported net sales of Rs 649.14 crore, revenue growth of 13.04%, and earnings per share of Rs 5.03.